Phase II Study of the Combination of Interleukin-2 with Zoledronic Acid As Maintenance Therapy Following Autologous Stem Cell Transplant in Patients with Multiple Myeloma / Gabriele, Buda; Rita, Fazzi; Giovanni, Carulli; Sara, Galimberti; Paola, Sammuri; Enrico, Orciuolo; Iacopo, Petrini; Accardi, Fabrizio; Laura, Notarfranchi; Giuliani, Nicola; Mario, Petrini. - In: BLOOD. - ISSN 0006-4971. - 128:22(2016).

Phase II Study of the Combination of Interleukin-2 with Zoledronic Acid As Maintenance Therapy Following Autologous Stem Cell Transplant in Patients with Multiple Myeloma

ACCARDI, FABRIZIO;GIULIANI, Nicola;
2016-01-01

Phase II Study of the Combination of Interleukin-2 with Zoledronic Acid As Maintenance Therapy Following Autologous Stem Cell Transplant in Patients with Multiple Myeloma / Gabriele, Buda; Rita, Fazzi; Giovanni, Carulli; Sara, Galimberti; Paola, Sammuri; Enrico, Orciuolo; Iacopo, Petrini; Accardi, Fabrizio; Laura, Notarfranchi; Giuliani, Nicola; Mario, Petrini. - In: BLOOD. - ISSN 0006-4971. - 128:22(2016).
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11381/2832926
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? 2
social impact